Cambridge, Massachusetts, United States · Hybrid
$88k–$132k/yr
Technical Specialist – Small Molecule Intellectual Property The Company Montai Therapeutics is a privately held, biotechnology company focused on harnessing AI to decode untapped diverse chemistry to develop breakthrough…
Skills: Accounting, US GAAP, Financial reporting, Month-end close, Account reconciliation
Cambridge, Massachusetts, United States • Hybrid
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Senior Accountant will manage month-end and quarter-end closing processes, including journal entries and account reconciliations. They will also assist in developing annual budgets, financial reporting, and implementing internal control improvements.
Candidates must hold a Bachelor's degree in accounting and possess strong experience with GAAP financial reporting. Proficiency in Microsoft Excel and experience with NetSuite are required, with a preference for CPA certification and biotechnology industry experience.
Montai Therapeutics is a privately held, biotechnology company focused on harnessing AI to decode untapped diverse chemistry to develop breakthrough oral medicines that can address persistent unmet needs in chronic disease. With our CONECTA® platform, Montai has built the world’s leading foundation models for decoding the complex language between nature’s bioactive chemistry and human biology – supercharging the drug discovery process with unprecedented optionality and predictability.
We are looking for a highly motivated, detailed-oriented and personable team player to join our Intellectual Property team as a Technical Specialist. This role will support the development and execution of the company’s intellectual property strategy for small molecule drug discovery programs and innovative biotech AI. Working closely with patent counsel, medicinal chemists, biologists, and external patent attorneys, the Technical Specialist will assist with invention harvesting, patent drafting, prior art analyses, competitive intelligence, and IP AI tool design and implementation.
This position is ideal for an early-career scientist with a strong background in organic or medicinal chemistry who is interested in intellectual property. The successful candidate will receive mentoring and on-the-job training in patent law and patent practice, with the opportunity to develop toward becoming a registered U.S. Patent Agent. No prior IP experience is required.
Privacy Notice for Applicants: When you apply for a role at Flagship Pioneering or one of its portfolio companies, we collect and use personal information you provide (such as your name, contact details, work history, and application materials) to evaluate your application, communicate with you, and comply with legal obligations. Your application data is processed through Greenhouse, our applicant tracking system, and may also be reviewed using AI-assisted screening tools. We do not sell your personal information. California residents have rights under the CCPA/CPRA including to know, delete, and opt out of the sharing of their personal information. If you are located in the EU or UK, we process your data under GDPR and you have rights to access, rectify, and erase your data. To exercise your rights or for questions, contact [email protected].
The salary range for this role is $88,000 - $132,000. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Montai Therapeutics currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on Montai Therapeutics's good faith estimate as of the date of publication and may be modified in the future.
Breakthrough small molecule medicines for chronic disease with unprecedented pathway precision and predictable discovery
Montai Therapeutics is pioneering at the intersection of technology, validated biology, and diverse, untapped human chemistry in pursuit of transformative medicines for chronic disease. Montai’s CONECTA platform enables the predictable discovery of efficacious small molecules that can precisely engage complex biologic targets and pathways and have the potential to become medicines for long-term use and earlier intervention.
Offices: Cambridge, MA, US
Breakthrough small molecule medicines for chronic disease with unprecedented pathway precision and predictable discovery
Montai Therapeutics is pioneering at the intersection of technology, validated biology, and diverse, untapped human chemistry in pursuit of transformative medicines for chronic disease. Montai’s CONECTA platform enables the predictable discovery of efficacious small molecules that can precisely engage complex biologic targets and pathways and have the potential to become medicines for long-term use and earlier intervention.
Offices: Cambridge, MA, US
